Siemens to acquire Bayer's Diagnostics Division

Expansion aims at high-growth molecular diagnostics market

Siemens has signed an agreement with Bayer to acquire the chemical and pharmaceutical company's Diagnostics Division.

Photo: Siemens to acquire Bayers Diagnostics Division

Siemens Medical Solutions (Med) reports that the acquisition will enable the firm to expand its position in the high-growth molecular diagnostics market. At the end of April, Siemens announced the planned acquisition of Diagnostic Products Corporation (DPC) in the USA, a leading company in immunodiagnostics. The purchase price for Bayer Diagnostics - which had sales of €1.4 billion and a double-digit EBITDA margin in fiscal 2005 - is roughly €4.2 billion.

‘Acquisition of Bayer Diagnostics is part of our targeted strategy to create the healthcare industry’s first integrated diagnostics company by combining the entire imaging diagnostics, laboratory diagnostics and clinical IT value chain under one roof,’ Dr Klaus Kleinfeld, Siemens President and CEO explained.

The company adds that the Bayer division acquisition will enable the Siemens Group to ‘...tap the rapidly growing market for molecular diagnostics based on gene analysis (nucleid acid testing). Bayer Diagnostics is also a world market-leader in clinical chemistry with a leading position in near-patient testing, laboratory automation and haematology (blood cell diagnostics).’


Read all latest stories

Related articles


Coronavirus countermeasures

Learning from China – the role of radiology in combatting COVID-19

As the first country to be hit by COVID-19, China learned a number of early lessons into how to combat the highly-infectious disease. With radiology teams playing an important role and utilising CT…


Siemens Healthineers at RSNA 2019

Join us as we enter the era of intelligent CT imaging

Curious about how intelligent imaging can work with you in CT? Then join us at this year’s RSNA, North Hall, Booth #7530, where you can experience our new Somatom X.cite and myExam Companion.



Healthcare: confidence in cloud computing grows

Consider the diagnostic and therapeutic possibilities resulting from access to pertinent data from thousands of anonymized patient medical scans. What new patterns, options, or evidence for…

Related products